Found 706 clinical trials

UPCC 06221: A Multicenter Open-label Exploratory Platform Trial to Evaluate Immunotherapy Combinations with Chemotherapy for the Treatment of Patients with Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)

TBD

99 years and younger

All

Phase 0

SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS

TBD

99 years and younger

All

Phase 0

A Phase 1 Multiple-Ascending-Dose Study to Assess the Safety Tolerability and Pharmacokinetics of BIIB105 Administered Intrathecally to Adults With Amyotrophic Lateral Sclerosis With or Without Poly-CAG Expansion in the Ataxin-2 Gene

TBD

99 years and younger

All

Phase 0

OBSERVATIONAL STUDY OF CONJUNCTIVITIS IN THE SETTING OF DUPIXENT TREATMENT FOR ATOPIC DERMATITis

TBD

99 years and younger

All

Phase 0

A Phase 1 Study of [225Ac]-FPI-1434 Injection in Patients with Advanced Solid Tumours

5.0

99 years and younger

All

Phase 1

Phase IB Study of Hepatic Chemoembolization Plus Axitinib and Hydrochlorquine for Liver-Dominant Metastatic Adenocarcinoma Of The Colon And Rectum

10.0

99 years and younger

All

Phase 1

UPCC 08421: Phase II Multicenter Trial of anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for Multiple Myeloma Patients with Sub-Optimal Response After Autologous Hematopoietic Cell Transplantation and Maintenance Lenalidomide

TBD

99 years and younger

All

Phase 0

UPCC 18920: A Phase 1 First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor in Subjects with HER2 Overexpressing Solid Tumors

0.0

99 years and younger

All

Phase 1

PennRad BioBank

100.0

99 years and younger

All

UPCC 04621: A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02C (Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy

TBD

99 years and younger

All

Phase 0

Found 706 clinical trials

UPCC 06221: A Multicenter Open-label Exploratory Platform Trial to Evaluate Immunotherapy Combinations with Chemotherapy for the Treatment of Patients with Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)

SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS

A Phase 1 Multiple-Ascending-Dose Study to Assess the Safety Tolerability and Pharmacokinetics of BIIB105 Administered Intrathecally to Adults With Amyotrophic Lateral Sclerosis With or Without Poly-CAG Expansion in the Ataxin-2 Gene

OBSERVATIONAL STUDY OF CONJUNCTIVITIS IN THE SETTING OF DUPIXENT TREATMENT FOR ATOPIC DERMATITis

A Phase 1 Study of [225Ac]-FPI-1434 Injection in Patients with Advanced Solid Tumours

Phase IB Study of Hepatic Chemoembolization Plus Axitinib and Hydrochlorquine for Liver-Dominant Metastatic Adenocarcinoma Of The Colon And Rectum

UPCC 08421: Phase II Multicenter Trial of anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for Multiple Myeloma Patients with Sub-Optimal Response After Autologous Hematopoietic Cell Transplantation and Maintenance Lenalidomide

UPCC 18920: A Phase 1 First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor in Subjects with HER2 Overexpressing Solid Tumors

PennRad BioBank

One platform. Various ways to connect patients to your clinical studies.

Contact Us

About Us

Our Solutions

For Industry

For Patients

Resources